We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Is Now The Perfect Time To Buy Blinkx Plc, Xaar plc, Mulberry Group PLC And DX (Group) PLC?

Should you add these 4 stocks to your portfolio? Blinkx Plc (LON: BLNX), Xaar plc (LON: XAR), Mulberry Group PLC (LON: MUL) and DX (Group) PLC (LON: DX)

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

The short term movements of share prices can be very difficult to understand. Sometimes they rise when the outlook for a company is poor (but not as poor as was previously expected) and other times they fall even though a company has posted record-breaking profits. As such, Ben Graham perhaps summed it up best when he said that ‘in the short run the market is a voting machine, but in the long run it is a weighing machine’. In other words, sentiment may matter in the short run, but quality shines through in the longer term.

For example, the share price performance of digital inkjet developer, Xaar (LSE: XAR), is rather surprising. That’s because it has risen by 38% since the turn of the year despite Xaar being forecast to post a fall of 35% in its earnings for the full year. Certainly, Xaar is expected to improve on its performance next year, with net profit growth of 12% being pencilled in, but even if it meets its current guidance its shares still trade on a relatively high forward price to earnings (P/E) ratio of 26.9. As such, they appear to be worth avoiding even though they are up by a further 6.5% today.

Should you buy Mulberry Group Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Meanwhile, the share price of fashion company, Mulberry (LSE: MUL), is also somewhat surprising. It fell heavily in 2012 and 2013 as its strategy of increasing prices backfired and many of its loyal customer base switched to what were perceived to be better value products. However, under a refreshed strategy, Mulberry is now forecast to reverse the slump in its profitability, with net profit forecast to treble this year and rise by 2.5 times next year. Despite this, Mulberry’s share price has only risen by 9% since the turn of the year and, with it trading on a price to earnings growth (PEG) ratio of 0.4, it seems to be worth buying.

It’s a similar story with delivery services company, DX (LSE: DX). It had a difficult year in 2014, posting a pretax loss of £55m. However, it is due to reverse this in 2015, with a pretax profit of £26m being forecast and, while profit growth of 4% next year is rather pedestrian, DX appears to be worth more than its current share price. That’s because it trades on a P/E ratio of just 7.9 and, furthermore, offers a yield of 7.1% at the present time, with dividends being covered 1.8 times by profit. As such, it appears to offer a potent mix of value and income potential that make it an appealing buy.

Of course, not all share price movements are so difficult to understand. For example, online advertising company, Blinkx (LSE: BLNX), has seen its share price fall by 86% since the start of 2014 as the company has moved from being a highly profitable business into a loss-making one. And, while Blinkx is currently transitioning its business model to mobile and is restructuring its marketing, divisions and wider product offering, a lack of profitability is likely to hold it back over the short to medium term. And, with further losses expected in the current year and next year, further weakness could lie ahead for Blinkx.

However, with a dirt cheap valuation (it trades on a price to book ratio of just 0.75) and a cash pile that provides it with the time and space to deliver a more focused offering, Blinkx seems to be worth buying at the present time. Certainly, it is relatively risky, but the potential rewards seem to justify buying with such an uncertain outlook.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Up nearly 1,400% in 5 years! But are Rolls-Royce shares still secretly undervalued?

After skyrocketing, Rolls-Royce shares are now near an all-time high, but could the engineering giant still have more room to…

Read more »

Happy senior couple hugging and enjoying retirement at home
Investing Articles

By mid-2027, analysts expect £5,000 in Barclays shares to be worth…

Barclays shares have outperformed the FTSE 100 by a wide margin over the last year. And City analysts expect to…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Near 5-year lows, here’s what the experts say about the Diageo share price

Ben McPoland's questioning his sanity after investing in Diageo. Where do institutional analysts see its share price heading over the…

Read more »

British Airways cabin crew with mobile device
Investing Articles

Up 165% but still with a P/E of 7.9. Is the IAG share price a generational bargain?

The IAG share price has been on fire for the last two years, delivering some of the biggest returns in…

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Here’s the latest Vodafone share price forecasts for 2027

Up 35% in 12 months, the Vodafone share price is beating the stock market right now, but can this momentum…

Read more »